Ads
related to: Skyrizi- SKYRIZI® Dosing Info
Learn About The Dosing Frequency Of
SKYRIZI®. See Results For SKYRIZI®.
- Support
Find Resources To Help You
Get Started With Treatment.
- Register For More Info
Be The First To Know About
SKYRIZI Info. Sign Up Now.
- SKYRIZI Resources
Skyrizi Complete Offers Resources
To Stay On Track With Treatment.
- SKYRIZI Results
See Results from SKYRIZI
From Real Clinical Trial Patients.
- Doctor Discussion Tool
Use Our Free Tool To Help
Prepare For Your Next Visit.
- SKYRIZI® Dosing Info
Search results
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 6 days agoAbbVie’s top line is being driven by sales of new immunology drugs, Skyrizi and Rinvoq. The Zacks...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks· 6 days agoFree Report) will announce quarterly earnings of $2.26 per share in its forthcoming report, representing a decline of 8.1% year over year. Ahead of a company's earnings disclosure, it is crucial ...
AbbVie tries to reassure investors on Humira biosimilar threat
BioPharma Dive via Yahoo Finance· 3 days agoAlthough that has meant Humira’s market share dropped from 96% to 81% over two weeks, Stewart said...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 2 days ago"This is despite the significant increase in U.S. biosimilar market share in April," Leerink...
‘AI Craze’ Powers Best Week in 2024 for Stocks: Markets Wrap
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- A rally in the world’s largest technology companies lifted stocks, with Wall Street...
Drugmaker AbbVie expects Humira volume erosion to worsen By Reuters
Investing.com· 3 days agoIts shares were down 2% in morning trade on Friday, after the company forecast U.S. Humira sales...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 5 days agoThe Zacks Consensus Estimate is pegged at $2.26 per share. AbbVie’s top line is expected to have...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Isn't
Investor's Business Daily· 2 days agoShares tumbled despite a first-quarter beat and earnings guidance increase.
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 days agoTotal net revenues were $12.3 billion approximately $400 million ahead of our expectations. This overachievement was driven by our ex-Humira growth...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 2 days agoFurther, even without Humira driving top-line growth, AbbVie's underlying business remains solid....
Ads
related to: Skyrizi
